---

Recent insights into the role of antifibrotic drugs in the management of idiopathic pulmonary fibrosis (IPF)

---

Review Article

Author Details : Raja Chakraverty*, Jyotirmoy Bondyopadhyay

Volume : 10, Issue : 1, Year : 2023

Article Page : 3-6

https://doi.org/10.18231/j.ijpp.2023.002

Suggest article by email

Get Permission

---

Abstract

Idiopathic aspiratory fibrosis (IPF) is the most well-known sort of idiopathic interstitial pneumonia (IIP). IIPs are precipitously shappening (idiopathic) diffuse parenchymal lung illnesses. IPF is characterized as a precipitouly happening (idiopathic) explicit type of persistent fibrosing interstitial pneumonia restricted to the lung and related with an example of Usual Interstitial Pneumonia (UIP) on imaging or histology. Pleasant rules for the analysis of Interstitial Lung Disease (ILD), preceding thought for against fibrotic treatment, specify that the conclusion of ILD has been made by a multidisciplinary group (MDT).

Keywords: IPF, Pirfenidone, Nintedanib, NAC, Antifibrotics

How to cite : Chakraverty R, Bondyopadhyay J, Recent insights into the role of antifibrotic drugs in the management of idiopathic pulmonary fibrosis (IPF). Indian J Pharm Pharmacol 2023;10(1):3-6

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.